{
  "question": "q20",
  "model_1": "Qwen3.8-27B-UD-Q6_K_XL",
  "model_2": "claude-opus-5",
  "answer_a_was": "claude-opus-5",
  "answer_b_was": "Qwen3.8-27B-UD-Q6_K_XL",
  "verdict_code": "TIE",
  "winner": "TIE",
  "judge_model": "openai/gpt-5.6-sol",
  "server_model": "openai/gpt-5.6-sol",
  "provider": "OpenAI",
  "finish_reason": "stop",
  "usage": {
    "prompt_tokens": 16670,
    "completion_tokens": 2550,
    "total_tokens": 19220,
    "cost": 0.18068375,
    "is_byok": false,
    "prompt_tokens_details": {
      "cached_tokens": 0,
      "cache_write_tokens": 16667,
      "audio_tokens": 0,
      "video_tokens": 0
    },
    "cost_details": {
      "upstream_inference_cost": 0.18068375,
      "upstream_inference_prompt_cost": 0.10418375,
      "upstream_inference_completions_cost": 0.0765
    },
    "completion_tokens_details": {
      "reasoning_tokens": 2070,
      "image_tokens": 0,
      "audio_tokens": 0
    }
  },
  "eval_prompt_sha256": "7e58b951cb86e4deba3b60fd01e9b9bd247ebe9883e1c9e43b24acffb1fd4667",
  "report": "TIE, FUNCTIONALLY EQUIVALENT.\n\nBasis. Both answers direct Northgate to halt the existing process, preserve evidence, correct ARR and NRR, disclose the non-renewal, remediate the anchor through rescission or amended terms with a release, freeze the secondary, and negotiate any financing only after complete disclosure. Competent counsel following either answer reaches the same materially safe path for the company and board.\n\n[A] rejected: “The term sheet is unsigned and the commitment is not irrevocable” — record lacks the term-sheet provisions needed to establish revocability.\n[A] rejected: a rescission offer “declined with full information leaves no injury” — supplied Rule 4 does not state that a rejected offer extinguishes damages claims.\n[A] rejected: fraud liability is categorically “outside the D&O policy” and creates policy-rescission grounds — record lacks the policy terms.\n[B] rejected: “D&O insurance will likely deny coverage” — record lacks the policy terms.\n[A] rejected: a $130–165 million valuation range — record lacks market and operating inputs supporting that range.\n[A] rejected: stockholder consents will be required — record lacks the charter and transaction provisions needed to establish that requirement.\n\nFailed candidates. Binding-term-sheet caveat — no-safe-neutralization element failed because ordinary review of the term sheet resolves it before action.\nFailed candidates. Pulling the secondary versus permitting it after full disclosure — concrete-consequence element failed because the record does not establish that either lawful course harms Northgate.\nFailed candidates. Mandatory ten-business-day delay — concrete-consequence element failed because the record supplies no runway or timing facts showing benefit or harm from that period.\nFailed candidates. Milestone reset versus a broader reprice or restructure — concrete-consequence element failed because no resulting valuation, dilution, or financing outcome is established.\nFailed candidates. Insurance notice and coverage assertions — concrete-consequence element failed because no policy-based coverage outcome is established.\nFailed candidates. Effect of a declined rescission offer — different-conduct element failed because both answers recommend rescission or amended terms coupled with a release.\nFailed candidates. Valuation-range specificity — different-conduct element failed because both answers ultimately require negotiation on corrected metrics rather than action at a stated valuation.\n\nHard stop. The sentence cannot be completed with a concrete, record-supported consequence distinguishing the answers.",
  "judge_reasoning": "**Evaluating output format**\n\nI need to ensure that my output adheres exactly to the required format. It's vital to identify any candidate divergences or elements that haven't worked as expected. I’ll also need to assess any unsupported claims that may have been made during the process. Neutralization of those claims could be necessary to keep everything aligned with the guidelines. I'll work carefully to examine each part and confirm everything is functioning properly!**Analyzing claims and commitments**\n\nI’m seeing that A has made several unsupported overclaims, such as the belief that only rescission can reliably extinguish issues and that there’s no injury if rescission declines. There are complications like the potential binding nature of a term sheet and how valuation ranges play into this. B has a more nuanced stance and may lead to material action differences. I wonder if B could achieve better outcomes by clarifying term sheet binding status. A seems to misread key elements about commitment.**Evaluating A's postponements and claims**\n\nA is still postponing the necessary corrections. If investors are already irrevocably committed, I think the potential corrections may not cut off their reliance. It seems that B is trying to check whether claims can be preserved, but I wonder about the company's risk in that case. The record mentions commitment by the term sheet, but its unsigned nature is ambiguous. A's legal certainty appears misleading, failing to properly address binding investors. I should log all of this for clarity!**Considering A’s alternative and protections**\n\nA suggests that a release option exists, but simply declining a rescission offer may not extinguish claims. I’m concerned a client might mistakenly believe that declining the offer ends their claims. The rules indicate that a purchaser can pursue damages regardless of rescission, which seems contradictory to A. B believes a release is essential, and A suggests an anchor letter with two options: reset with a release or accept rescission to naturally unwind and release claims.",
  "_public_record": {
    "type": "published record",
    "policy": "../../PUBLIC_RECORD_POLICY.md",
    "transformations": [
      "non-substantive machine metadata normalized",
      "published-record annotation added"
    ]
  }
}